public health

Owing to the stigma associated with sexually transmitted infections patients may like to keep their illness private and decide instead to try self-treatment remedies from the internet. However such remedies may prove hazardous if the sellers do not provide detailed advice on adverse effects or on avoiding transmission and re-infection. We conducted an internet examine to determine the availability of treatments for STIs and the nature of information provided by vendors of these treatments. We identified a total of 77 treatments from 52 different companies most of which were sold from the UK and US. The available remedies were predominantly for topical use and consisted mainly of homeopathic remedies. Only a small proportion of the web-listed products gave details on adverse effects contraindications and interactions (22%. 25% and 9% respectively). Similarly web vendors seldom provided advice on treatment of sexual contacts (20% of chlamydia and 25% of gonorrhea treatments) or on preventive measures (13%). Conversely evidence of effectiveness was claimed for approximately 50% of the products. While treatments for certain STIs are widely available on the internet purchasers of such products may potentially suffer injure because of the lack of information on adverse effects interactions and contra-indications. Moreover we consider the paucity of preventive health advice to be a serious omission thereby leading to patients being needlessly exposed to and potentially re-infected with the causative pathogens. One of the major barriers in the management of sexually transmitted infections is the associated stigma that may prevent patients from seeking professional medical care [-]. While media campaigns may bring about to enhanced general awareness of STIs patients who shun the spotlight may move to lay systems of care in search of a quick and easy cure. Here the internet can offer a sense of privacy making it a useful confidential resource for information in stigmatized conditions and reaching subgroups that may not normally be captured through other means []. Recent research has highlighted the widespread Internet availability of self test kits for a number of conditions including Chlamydia []. The potentially easy access to diagnostic tests and treatments from the privacy of one's domiciliate may make the internet an appealing avenue for patients seeking remedies for their STIs. One of the major concerns regarding internet purchases is whether the appropriate safeguards have been put in place to protect the patient. Treatment of STIs is not a simple one-off solution – the remedies will inevitably fail if users are not advised on minimizing re-infection and concurrent treatment of sexual contacts. Moreover licensed drugs are tightly regulated and come with government approved information leaflets that help patients to check that the medication is indeed safe and suitable for them. This may not be the case for Internet purchases. As such we surveyed the availability of treatments for common STIs on the Internet and evaluated the product information and public health advice given by the vendors of such treatments. We conducted a systematic search of the internet using ' [infection] self treatment' as the search term where [infection] was substituted by one of the following STIs: genital warts. HPV genital herpes chlamydia gonorrhea and syphilis. There are a variety of search engines available for the retrieval of information from the internet. To increase the likelihood of finding treatments for STIs we used five search engines: Eighty percent of populate searching the internet would only use the first two pages retrieved by the search [9]. In order to replicate this typical behavior we opened all the links on the first two pages retrieved by the search engine plus all the sponsored links on those pages. For we also explored the first two pages of all the relevant 'clusters'. We visited websites that offered treatment of STIs (with or without offering concurrent diagnostic tests) and retrieved product data onto a database with predefined fields (Table ). We collected information on the type of treatments including its compounds if reported the dose and length of treatment the be whether interactions contraindications or side effects were reported and if advice regarding prevention of transmission or treatment of sexual partners was offered. The key criteria for inclusion onto the database were that the websites were selling products for the treatment of STIs; we also included website that sold information (rather than physical remedies) on how to treat the conditions (i e e-books). We only researched the websites and the products offered up to the point where payment was required. On completion of the database we aggregated the collected data and descriptively summarized the general characteristics of the available treatments. A be of 77 products from a total of 52 companies were identified in the search (Table ). These products were shipped from six different countries. The majority (61%) were from companies based in the United States followed by the United Kingdom (17%). The cost of the smallest pack for each of the treatments ranged from $14.95 to $290 (convey $51.76). The add up cost did not differed significantly between the different STIs. The types of active compounds present in the products identified were: homeopathic (73%) mainly for genital warts and herpes; antibiotics (8%) for the treatment of Chlamydia and Gonorrhea; and some chemical compounds (5%) like podophyllum and imiquimod for the treatment of genital warts. Information on the active compound was not available for 14%. Of the homeopathic remedies two (for the treatment of herpes) contained dilutions of viruses (including a variety of herpes viruses cytomegalovirus. Epstein Barr virus and poliomyelitis) that claimed to stimulate natural immunity to clear the infection. Two other websites offered e-books on proven treatments of genital warts with remedies that could be made with products home available; but there was not enough information on the websites to determine the exact nature of these products. Overall side effects were discussed in 22% of the products contraindications in 25% and interactions with other drugs in 9%. The reporting of these was better for treatments of bacterial infections for which it was also more likely that an online medical consultation was offered or that advice to seek medical attention in inspect of treatment failure would be given if treatment failed. Where align effects were discussed this related to skin irritation; also the commonest contraindication when mentioned was pregnancy and breastfeeding. However in the seven products where drug interactions were available four were related to antibiotics in which a pre-treatment form or some choose of virtual consultation was required. Inversely there were claims of beneficial properties in almost 50% of the products either by stating its effectiveness or by referring to approval by a regulatory body or the compliance with manufacturing regulations. Where studies were cited these were hard to track down or referred to empirical investigate. Testimonial from other patients was widely used by most of the websites as a form of qualitative evidence. Recommendation that sexual partners should also be treated or advice regarding prevention (e g use of condoms abstinence while on treatment testing for other STI etc.) was rarely given (13% had preventive messages). Partner treatment was recommended in 20% of treatments for chlamydia and 25% for gonorrhea (Table ). The internet may provide a sense of privacy as highlighted by behavioral research into stigmatized issues []. As a result people may move to the internet to seek help for a STI. In our study we identified many products on offer for symptomatic conditions with topical manifestations such as genital warts and herpes. Conversely there were far fewer treatments available for conditions such as Chlamydia or Gonorrhea infection that may not be obvious to the person suffering them. This may be because these conditions require specific testing to identify the causal agent or because a larger proportion of patients may be asymptomatic []. The cost of treatments on offer ranged from $14.95 to $290 making some of the treatments relatively affordable in comparison with the current cost of a prescription or the actual cost of some of the treatments recommended by accepted treatment guidelines [-]. On the other hand some treatments were relatively expensive which declare that treatment cost may not be an issue for some. Active components of the different treatment varied considerably. These were mainly homeopathic or herbal remedies. Although there is some empirical evidence that compounds like lemon balm and lysine may have antiviral properties [ ] there is not enough information in the websites that we identified to judge whether treatments are effective or not. Some vendors provided examples of clinical studies but the cited bear witness was limited to in-vitro research in the best cases or poor quality or doubtful studies in others. None of the websites offered information about well conducted randomized control trials in humans. While we do undergo serious misgivings around the lack of evidence on efficacy we are also equally concerned at the lost opportunity for essential public health advice on prevention and control of transmission the absence of which will negate the expected benefits on any treatment. There is evidence that co-infection with more than one STI can become []. Generally we found that no advice was given to test for concomitant infections. Also worryingly most of the vendors' websites we identified did not display information on prevention of transmission such as use of condoms or abstinence while on treatment. Nor did they recommend notification testing and treatment of sexual partners. The glaring lack of advice on avoiding re-infection and treatment of contacts means that some of these remedies are doomed to disappoint. Indeed this may alter to greater individual hazard and risk to the public from greater spread of the STIs. The majority of the products were from companies based in the US or the UK where there is good regulation of drugs and therapeutics. However as some of the products sold through the internet could be classed as herbal extracts topical applications or even beauty products they may be overlooked by regulations requiring a prescription from a qualified health professional. The lack of information on align effects contraindications or interaction is in differentiate with the many unsubstantiated claims of effectiveness; this may mislead potential buyers to accept these treatments are better than recommended pharmacological treatments. Moreover the absence of trial data on these products means that patients may inadvertently be paying for and using products which are unsafe or unsuitable for them. This study is limited by the lack of information on how many people find and buy products to self treat STIs via the internet. We are only able to comment on the amount of products and their affordability and hence speculate that a merchandise exists for these products. Anecdotally during the time that we were conducting the search a total of 21 items of four different products we identified for genital warts or genital herpes were sold through eBay; whereas the number of people that had viewed each product on sale ranged between 61 and 263 (based on values on the eBay counter for each page). Of the 4 products sold through a single eBay trader there were at least 29 confirmed buyers over the past 90 days who left positive feedback. This is likely to be a significant underestimate though as purchasers of such products may prefer not leave their details on the seller's feedback page. Also this study only focuses on one source of alternative treatment for STIs (i e the internet) and it does not address questions regarding accessibility and usage of these alternative sources. While we did not actually purchase any products other researchers have reported success in buying both prescription drugs and alternative therapies from Internet merchants[]. Unfortunately we are unable to explain the characteristics of populate that may access treatment for STIs in this way but merely speculate that if treatments are being sold and bought on the internet means that there are people willing to use alternative ways of accessing treatment. It is possible that populate who use the internet for such therapies are already well-versed with preventative measures and may be purchasing the treatment for both themselves and their partners. Conversely the lack of information from web traders on prevention may come up be a cynical way of ensuring tell visits from their customer locate. Further research may be needed to determine the role that alternative therapies and lay systems play in the treatment of STIs and therefore be able to asses the overall force that these may have in their epidemiology and transmission control. Regulatory agencies' websites in the UK and US inform consumers of the problems of purchasing treatments through the internet and of the doubtful quality of some of the products [ ]. It has also been suggested that doctors be to advise their patients against using drugs bought on the internet []. We argue that some patients with STIs may not even present to a doctor at all. Indeed government information campaigns that change magnitude the awareness of STIs may potentially increase the merchandise for STI remedies on the Internet given the stigmatized nature of STIs and the relative convenience of online purchases. The marketing and professional regulations of some of these products or companies may not be as tight as those provided by registered pharmaceutical companies and the medical establishment thus resulting in lack of information about side-effects contraindications or interactions. Furthermore because of the lack of contact with health care professionals a valuable opportunity for patient education and prevention advice is lost. As regulation of vendors on the Internet is unlikely to ever be successful we propose that the public should be educated on the dangers of using self-treatment of STIs particularly where preventative measures are essential in stopping re-infection. Government agencies could explore the possibility of using the same search engines that are used by potential customers of these products ensuring that similar searches also return prominent links to promotional sites warning of the dangers and giving appropriate preventive advice.

Forex Groups - Tips on Trading

Related article:
http://www.biomedcentral.com/1471-2458/7/333

comments | Add comment | Report as Spam

Owing to the stigma associated with sexually transmitted infections patients may prefer to keep their illness private and decide instead to try self-treatment remedies from the internet. However such remedies may prove hazardous if the sellers do not provide detailed advice on adverse effects or on avoiding transmission and re-infection. We conducted an internet examine to determine the availability of treatments for STIs and the nature of information provided by vendors of these treatments. We identified a total of 77 treatments from 52 different companies most of which were sold from the UK and US. The available remedies were predominantly for topical use and consisted mainly of homeopathic remedies. Only a small proportion of the web-listed products gave details on adverse effects contraindications and interactions (22%. 25% and 9% respectively). Similarly web vendors seldom provided advice on treatment of sexual contacts (20% of chlamydia and 25% of gonorrhea treatments) or on preventive measures (13%). Conversely evidence of effectiveness was claimed for approximately 50% of the products. While treatments for certain STIs are widely available on the internet purchasers of such products may potentially suffer injure because of the lack of information on adverse effects interactions and contra-indications. Moreover we consider the paucity of preventive health advice to be a serious omission thereby leading to patients being needlessly exposed to and potentially re-infected with the causative pathogens. One of the major barriers in the management of sexually transmitted infections is the associated stigma that may prevent patients from seeking professional medical compassionate [-]. While media campaigns may lead to enhanced general awareness of STIs patients who avoid the spotlight may turn to lay systems of compassionate in search of a quick and easy cure. Here the internet can offer a comprehend of privacy making it a useful confidential resource for information in stigmatized conditions and reaching subgroups that may not normally be captured through other means []. Recent research has highlighted the widespread Internet availability of self test kits for a number of conditions including Chlamydia []. The potentially easy access to diagnostic tests and treatments from the privacy of one's home may make the internet an appealing avenue for patients seeking remedies for their STIs. One of the study concerns regarding internet purchases is whether the appropriate safeguards undergo been put in place to protect the patient. Treatment of STIs is not a simple one-off solution – the remedies will inevitably fail if users are not advised on minimizing re-infection and concurrent treatment of sexual contacts. Moreover licensed drugs are tightly regulated and come with government approved information leaflets that back up patients to check that the medication is indeed safe and suitable for them. This may not be the case for Internet purchases. As such we surveyed the availability of treatments for common STIs on the Internet and evaluated the product information and public health advice given by the vendors of such treatments. We conducted a systematic search of the internet using ' [infection] self treatment' as the search term where [infection] was substituted by one of the following STIs: genital warts. HPV genital herpes chlamydia gonorrhea and syphilis. There are a variety of search engines available for the retrieval of information from the internet. To increase the likelihood of finding treatments for STIs we used five search engines: Eighty percent of people searching the internet would only use the first two pages retrieved by the search [9]. In request to replicate this typical behavior we opened all the links on the first two pages retrieved by the examine engine plus all the sponsored links on those pages. For we also explored the first two pages of all the relevant 'clusters'. We visited websites that offered treatment of STIs (with or without offering concurrent diagnostic tests) and retrieved product data onto a database with predefined fields (Table ). We collected information on the type of treatments including its compounds if reported the dose and length of treatment the cost whether interactions contraindications or side effects were reported and if advice regarding prevention of transmission or treatment of sexual partners was offered. The key criteria for inclusion onto the database were that the websites were selling products for the treatment of STIs; we also included website that sold information (rather than physical remedies) on how to treat the conditions (i e e-books). We only researched the websites and the products offered up to the point where payment was required. On completion of the database we aggregated the collected data and descriptively summarized the general characteristics of the available treatments. A total of 77 products from a be of 52 companies were identified in the search (Table ). These products were shipped from six different countries. The majority (61%) were from companies based in the United States followed by the United Kingdom (17%). The cost of the smallest pack for each of the treatments ranged from $14.95 to $290 (mean $51.76). The average cost did not differed significantly between the different STIs. The types of active compounds present in the products identified were: homeopathic (73%) mainly for genital warts and herpes; antibiotics (8%) for the treatment of Chlamydia and Gonorrhea; and some chemical compounds (5%) like podophyllum and imiquimod for the treatment of genital warts. Information on the active compound was not available for 14%. Of the homeopathic remedies two (for the treatment of herpes) contained dilutions of viruses (including a variety of herpes viruses cytomegalovirus. Epstein Barr virus and poliomyelitis) that claimed to stimulate natural immunity to clear the infection. Two other websites offered e-books on proven treatments of genital warts with remedies that could be made with products home available; but there was not enough information on the websites to determine the exact nature of these products. Overall side effects were discussed in 22% of the products contraindications in 25% and interactions with other drugs in 9%. The reporting of these was exceed for treatments of bacterial infections for which it was also more likely that an online medical consultation was offered or that advice to desire medical attention in inspect of treatment failure would be given if treatment failed. Where side effects were discussed this related to skin irritation; also the commonest contraindication when mentioned was pregnancy and breastfeeding. However in the seven products where drug interactions were available four were related to antibiotics in which a pre-treatment form or some choose of virtual consultation was required. Inversely there were claims of beneficial properties in almost 50% of the products either by stating its effectiveness or by referring to approval by a regulatory body or the compliance with manufacturing regulations. Where studies were cited these were hard to track drink or referred to empirical research. Testimonial from other patients was widely used by most of the websites as a create of qualitative evidence. Recommendation that sexual partners should also be treated or advice regarding prevention (e g use of condoms abstinence while on treatment testing for other STI etc.) was rarely given (13% had preventive messages). Partner treatment was recommended in 20% of treatments for chlamydia and 25% for gonorrhea (Table ). The internet may provide a sense of privacy as highlighted by behavioral research into stigmatized issues []. As a result people may move to the internet to seek help for a STI. In our study we identified many products on offer for symptomatic conditions with topical manifestations such as genital warts and herpes. Conversely there were far fewer treatments available for conditions such as Chlamydia or Gonorrhea infection that may not be obvious to the person suffering them. This may be because these conditions require specific testing to identify the causal agent or because a larger harmonise of patients may be asymptomatic []. The cost of treatments on furnish ranged from $14.95 to $290 making some of the treatments relatively affordable in comparison with the current cost of a prescription or the actual be of some of the treatments recommended by accepted treatment guidelines [-]. On the other hand some treatments were relatively expensive which suggest that treatment cost may not be an air for some. Active components of the different treatment varied considerably. These were mainly homeopathic or herbal remedies. Although there is some empirical bear witness that compounds like lemon balm and lysine may undergo antiviral properties [ ] there is not enough information in the websites that we identified to judge whether treatments are effective or not. Some vendors provided examples of clinical studies but the cited evidence was limited to in-vitro research in the best cases or poor quality or doubtful studies in others. None of the websites offered information about well conducted randomized control trials in humans. While we do have serious misgivings around the lack of bear witness on efficacy we are also equally concerned at the lost opportunity for essential public health advice on prevention and hold back of transmission the absence of which will depart the expected benefits on any treatment. There is bear witness that co-infection with more than one STI can become []. Generally we found that no advice was given to test for concomitant infections. Also worryingly most of the vendors' websites we identified did not display information on prevention of transmission such as use of condoms or abstinence while on treatment. Nor did they recommend notification testing and treatment of sexual partners. The glaring lack of advice on avoiding re-infection and treatment of contacts means that some of these remedies are doomed to fail. Indeed this may contribute to greater individual hazard and risk to the public from greater spread of the STIs. The majority of the products were from companies based in the US or the UK where there is good regulation of drugs and therapeutics. However as some of the products sold through the internet could be classed as herbal extracts topical applications or even beauty products they may be overlooked by regulations requiring a prescription from a qualified health professional. The lack of information on side effects contraindications or interaction is in contrast with the many unsubstantiated claims of effectiveness; this may mislead potential buyers to accept these treatments are better than recommended pharmacological treatments. Moreover the absence of trial data on these products means that patients may inadvertently be paying for and using products which are unsafe or unsuitable for them. This study is limited by the lack of information on how many people access and buy products to self treat STIs via the internet. We are only able to mention on the amount of products and their affordability and hence anticipate that a market exists for these products. Anecdotally during the time that we were conducting the examine a be of 21 items of four different products we identified for genital warts or genital herpes were sold through eBay; whereas the be of populate that had viewed each product on sale ranged between 61 and 263 (based on values on the eBay counter for each summon). Of the 4 products sold through a single eBay trader there were at least 29 confirmed buyers over the past 90 days who left positive feedback. This is likely to be a significant underestimate though as purchasers of such products may like not leave their details on the seller's feedback page. Also this study only focuses on one source of alternative treatment for STIs (i e the internet) and it does not address questions regarding accessibility and usage of these alternative sources. While we did not actually purchase any products other researchers have reported success in buying both prescription drugs and alternative therapies from Internet merchants[]. Unfortunately we are unable to explain the characteristics of people that may find treatment for STIs in this way but merely anticipate that if treatments are being sold and bought on the internet means that there are people willing to use alternative ways of accessing treatment. It is possible that people who use the internet for such therapies are already well-versed with preventative measures and may be purchasing the treatment for both themselves and their partners. Conversely the lack of information from web traders on prevention may well be a cynical way of ensuring tell visits from their customer locate. advance research may be needed to determine the role that alternative therapies and lay systems play in the treatment of STIs and therefore be able to asses the overall force that these may have in their epidemiology and transmission control. Regulatory agencies' websites in the UK and US warn consumers of the problems of purchasing treatments through the internet and of the doubtful quality of some of the products [ ]. It has also been suggested that doctors need to advise their patients against using drugs bought on the internet []. We argue that some patients with STIs may not change surface present to a adulterate at all. Indeed government information campaigns that increase the awareness of STIs may potentially change magnitude the merchandise for STI remedies on the Internet given the stigmatized nature of STIs and the relative convenience of online purchases. The marketing and professional regulations of some of these products or companies may not be as tight as those provided by registered pharmaceutical companies and the medical establishment thus resulting in lack of information about side-effects contraindications or interactions. Furthermore because of the lack of contact with health care professionals a valuable opportunity for patient education and prevention advice is lost. As regulation of vendors on the Internet is unlikely to ever be successful we propose that the public should be educated on the dangers of using self-treatment of STIs particularly where preventative measures are essential in stopping re-infection. Government agencies could explore the possibility of using the same search engines that are used by potential customers of these products ensuring that similar searches also go prominent links to promotional sites warning of the dangers and giving appropriate preventive advice.

Forex Groups - Tips on Trading

Related article:
http://www.biomedcentral.com/1471-2458/7/333

comments | Add comment | Report as Spam

Owing to the stigma associated with sexually transmitted infections patients may prefer to keep their illness private and choose instead to try self-treatment remedies from the internet. However such remedies may prove hazardous if the sellers do not give detailed advice on adverse effects or on avoiding transmission and re-infection. We conducted an internet search to cause the availability of treatments for STIs and the nature of information provided by vendors of these treatments. We identified a total of 77 treatments from 52 different companies most of which were sold from the UK and US. The available remedies were predominantly for topical use and consisted mainly of homeopathic remedies. Only a small proportion of the web-listed products gave details on adverse effects contraindications and interactions (22%. 25% and 9% respectively). Similarly web vendors seldom provided advice on treatment of sexual contacts (20% of chlamydia and 25% of gonorrhea treatments) or on preventive measures (13%). Conversely bear witness of effectiveness was claimed for approximately 50% of the products. While treatments for certain STIs are widely available on the internet purchasers of such products may potentially suffer harm because of the lack of information on adverse effects interactions and contra-indications. Moreover we consider the paucity of preventive health advice to be a serious omission thereby leading to patients being needlessly exposed to and potentially re-infected with the causative pathogens. One of the major barriers in the management of sexually transmitted infections is the associated stigma that may prevent patients from seeking professional medical care [-]. While media campaigns may lead to enhanced command awareness of STIs patients who shun the bring out may turn to lay systems of compassionate in search of a quick and easy cure. Here the internet can offer a sense of privacy making it a useful confidential resource for information in stigmatized conditions and reaching subgroups that may not normally be captured through other means []. Recent research has highlighted the widespread Internet availability of self test kits for a number of conditions including Chlamydia []. The potentially easy find to diagnostic tests and treatments from the privacy of one's home may make the internet an appealing avenue for patients seeking remedies for their STIs. One of the major concerns regarding internet purchases is whether the appropriate safeguards have been put in place to protect the patient. Treatment of STIs is not a simple one-off solution – the remedies ordain inevitably disappoint if users are not advised on minimizing re-infection and concurrent treatment of sexual contacts. Moreover licensed drugs are tightly regulated and go with government approved information leaflets that help patients to check that the medication is indeed safe and suitable for them. This may not be the inspect for Internet purchases. As such we surveyed the availability of treatments for common STIs on the Internet and evaluated the product information and public health advice given by the vendors of such treatments. We conducted a systematic search of the internet using ' [infection] self treatment' as the search term where [infection] was substituted by one of the following STIs: genital warts. HPV genital herpes chlamydia gonorrhea and syphilis. There are a variety of search engines available for the retrieval of information from the internet. To increase the likelihood of finding treatments for STIs we used five examine engines: Eighty percent of populate searching the internet would only use the first two pages retrieved by the examine [9]. In order to replicate this typical behavior we opened all the links on the first two pages retrieved by the search engine plus all the sponsored links on those pages. For we also explored the first two pages of all the relevant 'clusters'. We visited websites that offered treatment of STIs (with or without offering concurrent diagnostic tests) and retrieved product data onto a database with predefined fields (delay ). We collected information on the write of treatments including its compounds if reported the dose and length of treatment the cost whether interactions contraindications or side effects were reported and if advice regarding prevention of transmission or treatment of sexual partners was offered. The key criteria for inclusion onto the database were that the websites were selling products for the treatment of STIs; we also included website that sold information (rather than physical remedies) on how to treat the conditions (i e e-books). We only researched the websites and the products offered up to the point where payment was required. On completion of the database we aggregated the collected data and descriptively summarized the general characteristics of the available treatments. A total of 77 products from a be of 52 companies were identified in the search (delay ). These products were shipped from six different countries. The majority (61%) were from companies based in the United States followed by the United Kingdom (17%). The cost of the smallest pack for each of the treatments ranged from $14.95 to $290 (convey $51.76). The average cost did not differed significantly between the different STIs. The types of active compounds present in the products identified were: homeopathic (73%) mainly for genital warts and herpes; antibiotics (8%) for the treatment of Chlamydia and Gonorrhea; and some chemical compounds (5%) like podophyllum and imiquimod for the treatment of genital warts. Information on the active compound was not available for 14%. Of the homeopathic remedies two (for the treatment of herpes) contained dilutions of viruses (including a variety of herpes viruses cytomegalovirus. Epstein Barr virus and poliomyelitis) that claimed to stimulate natural immunity to clear the infection. Two other websites offered e-books on proven treatments of genital warts with remedies that could be made with products domiciliate available; but there was not enough information on the websites to determine the claim nature of these products. Overall align effects were discussed in 22% of the products contraindications in 25% and interactions with other drugs in 9%. The reporting of these was better for treatments of bacterial infections for which it was also more likely that an online medical consultation was offered or that advice to seek medical attention in case of treatment failure would be given if treatment failed. Where side effects were discussed this related to skin irritation; also the commonest contraindication when mentioned was pregnancy and breastfeeding. However in the seven products where drug interactions were available four were related to antibiotics in which a pre-treatment form or some choose of virtual consultation was required. Inversely there were claims of beneficial properties in almost 50% of the products either by stating its effectiveness or by referring to approval by a regulatory be or the compliance with manufacturing regulations. Where studies were cited these were hard to track down or referred to empirical research. Testimonial from other patients was widely used by most of the websites as a form of qualitative evidence. Recommendation that sexual partners should also be treated or advice regarding prevention (e g use of condoms abstinence while on treatment testing for other STI etc.) was rarely given (13% had preventive messages). Partner treatment was recommended in 20% of treatments for chlamydia and 25% for gonorrhea (Table ). The internet may provide a sense of privacy as highlighted by behavioral investigate into stigmatized issues []. As a result people may turn to the internet to seek help for a STI. In our study we identified many products on furnish for symptomatic conditions with topical manifestations such as genital warts and herpes. Conversely there were far fewer treatments available for conditions such as Chlamydia or Gonorrhea infection that may not be obvious to the person suffering them. This may be because these conditions demand specific testing to determine the causal agent or because a larger proportion of patients may be asymptomatic []. The cost of treatments on offer ranged from $14.95 to $290 making some of the treatments relatively affordable in comparison with the current be of a prescription or the actual be of some of the treatments recommended by accepted treatment guidelines [-]. On the other transfer some treatments were relatively expensive which suggest that treatment cost may not be an issue for some. Active components of the different treatment varied considerably. These were mainly homeopathic or herbal remedies. Although there is some empirical evidence that compounds desire lemon balm and lysine may have antiviral properties [ ] there is not enough information in the websites that we identified to adjudicate whether treatments are effective or not. Some vendors provided examples of clinical studies but the cited evidence was limited to in-vitro research in the best cases or poor quality or doubtful studies in others. None of the websites offered information about well conducted randomized control trials in humans. While we do have serious misgivings around the lack of evidence on efficacy we are also equally concerned at the lost opportunity for essential public health advice on prevention and control of transmission the absence of which will negate the expected benefits on any treatment. There is bear witness that co-infection with more than one STI can become []. Generally we found that no advice was given to test for concomitant infections. Also worryingly most of the vendors' websites we identified did not display information on prevention of transmission such as use of condoms or abstinence while on treatment. Nor did they recommend notification testing and treatment of sexual partners. The glaring lack of advice on avoiding re-infection and treatment of contacts means that some of these remedies are doomed to fail. Indeed this may contribute to greater individual hazard and risk to the public from greater move of the STIs. The majority of the products were from companies based in the US or the UK where there is good regulation of drugs and therapeutics. However as some of the products sold through the internet could be classed as herbal extracts topical applications or even beauty products they may be overlooked by regulations requiring a prescription from a qualified health professional. The lack of information on side effects contraindications or interaction is in differentiate with the many unsubstantiated claims of effectiveness; this may mislead potential buyers to believe these treatments are better than recommended pharmacological treatments. Moreover the absence of trial data on these products means that patients may inadvertently be paying for and using products which are unsafe or unsuitable for them. This study is limited by the lack of information on how many populate access and buy products to self treat STIs via the internet. We are only able to comment on the amount of products and their affordability and hence speculate that a merchandise exists for these products. Anecdotally during the measure that we were conducting the search a total of 21 items of four different products we identified for genital warts or genital herpes were sold through eBay; whereas the number of people that had viewed each product on sale ranged between 61 and 263 (based on values on the eBay counter for each summon). Of the 4 products sold through a single eBay trader there were at least 29 confirmed buyers over the past 90 days who left positive feedback. This is likely to be a significant underestimate though as purchasers of such products may like not leave their details on the seller's feedback page. Also this study only focuses on one source of alternative treatment for STIs (i e the internet) and it does not address questions regarding accessibility and usage of these alternative sources. While we did not actually purchase any products other researchers have reported success in buying both prescription drugs and alternative therapies from Internet merchants[]. Unfortunately we are unable to explain the characteristics of people that may access treatment for STIs in this way but merely speculate that if treatments are being sold and bought on the internet means that there are people willing to use alternative ways of accessing treatment. It is possible that people who use the internet for such therapies are already well-versed with preventative measures and may be purchasing the treatment for both themselves and their partners. Conversely the lack of information from web traders on prevention may well be a cynical way of ensuring repeat visits from their customer base. advance investigate may be needed to determine the role that alternative therapies and lay systems play in the treatment of STIs and therefore be able to asses the overall force that these may undergo in their epidemiology and transmission control. Regulatory agencies' websites in the UK and US warn consumers of the problems of purchasing treatments through the internet and of the doubtful quality of some of the products [ ]. It has also been suggested that doctors need to advise their patients against using drugs bought on the internet []. We argue that some patients with STIs may not even present to a doctor at all. Indeed government information campaigns that increase the awareness of STIs may potentially increase the market for STI remedies on the Internet given the stigmatized nature of STIs and the relative convenience of online purchases. The marketing and professional regulations of some of these products or companies may not be as tight as those provided by registered pharmaceutical companies and the medical establishment thus resulting in lack of information about side-effects contraindications or interactions. Furthermore because of the lack of contact with health care professionals a valuable opportunity for patient education and prevention advice is lost. As regulation of vendors on the Internet is unlikely to ever be successful we propose that the public should be educated on the dangers of using self-treatment of STIs particularly where preventative measures are essential in stopping re-infection. Government agencies could explore the possibility of using the same search engines that are used by potential customers of these products ensuring that similar searches also return prominent links to promotional sites warning of the dangers and giving appropriate preventive advice.

Forex Groups - Tips on Trading

Related article:
http://www.biomedcentral.com/1471-2458/7/333

comments | Add comment | Report as Spam

complex. Most people who become infected with M tuberculosis are able to contain the organism and prevent it from replicating thus preventing disease development. M tuberculosis can survive for years but remain inactive within an individual. The infected person develops no symptoms or detectable signs of infection during this time. This condition is called latent tuberculosis infection (LTBI). Many populate with LTBI never create TB but in some individuals especially those with impaired immunity bacteria reactivate and cause TB disease. The main method to diagnosis LTBI is by tuberculin skin testing (TST). When tuberculin testing material is injected intradermally usually on the volar aspect of the forearm individuals infected with develop a delayed cell-mediated reaction within 48-72 hours. This manifests as an induration of the skin at the site of injection. False positive and false negative reactions can occur with tuberculin skin testing due to technical or biological causes or both. For a discussion of tuberculin testing and diagnosis of tuberculosis infection gratify have in mind to the current issue of the Canadian Tuberculosis Standards which may be viewed at www publichealth gc ca/tuberculosis. Targeted tuberculin testing for LTBI is a strategic component of TB control that identifies persons at high risk for developing TB and who would benefit by treatment of LTBI. While tuberculin skin testing is commonly performed background prevalence of LTBI is seldom available for comparison. This compendium of Canadian LTBI prevalence rates was compiled to address this situation. Both published and unpublished materials were sought for the compendium. Results of TST were used as a surrogate of LTBI. For inclusion data must be based on screening of a Canadian population and data from contact investigations were only included if there was no evidence of recent transmission. PubMed was used to locate peer-reviewed articles of Canadian LTBI data using a variety of search terms related to TB infection. LTBI and Canada. Terms were broadened to include TB related activities where LTBI data may be collected. The challenge of the literature search lies in the fact that LTBI may not be mentioned in the title but such data are present in the text e g article on the decline of TB or tuberculosis infection is in the title but the content only addresses converters. In order to sight as many relevant articles as possible bibliographies were also searched for related publications..

Forex Groups - Tips on Trading

Related article:
http://www.phac-aspc.gc.ca/tbpc-latb/ltbi_compendium-eng.html

comments | Add comment | Report as Spam

Speaking at a recent meeting of the American Public Health Association (APHA) in Washington. D. C. federal health leaders and researchers outlined evidence that efforts to originate in obesity can also benefit the fight against global warming the Associated touch reports. One researcher suggests for instance that if Americans between the ages of 10 and 74 replaced driving with 30 minutes of walking each day for one year they would not only collectively lose more than 3 billion pounds or about 13 pounds each but also hold 6.5 billion gallons of gasoline and decrease carbon dioxide emissions by 64 million tons. A professor at the Johns Hopkins School of Public Health meanwhile notes that efforts to reduce meat consumption could undergo similar benefits. Americans currently eat 1.6 times as much meat as recommended under federal guidelines he says adding that the meat sector consumes a disproportionate be of energy and arrive compared with vegetable grain and fruit producers. Noting these connections between obesity and climate change the director of the Centers for Disease Control and Prevention says the agency is considering promoting the "co-benefits" of tackling both issues through lifestyle changes such as everyday apply. The executive director of the APHA meanwhile says the group plans to pursue shared solutions to obesity and climate change a pairing that could "show the greatest public health opportunity that we've had in a century," according to the president of the International Association for Ecology and Health (Borenstein. AP/Yahoo! News. 11/11/07).    

Forex Groups - Tips on Trading

Related article:
http://www.rwjf.org/programareas/features/digest.jsp?id=6694&pid=1141

comments | Add comment | Report as Spam

When public health emergencies strike how do we meet the needs of different populations and in particular people living with disabilities?Those attending yesterday’s meeting on improving public health preparedness systems heard from Eileen Elias. MEd deputy director of the at the U. S. Department of Health and Human Services and Leon Larson senior program analyst in the on just that affect. The presenters described the limited mechanisms currently in displace at the federal express and private levels to compel comprehensive preparedness planning that addresses the unique challenges facing populate with disabilities. Elias pointed to Hurricane Katrina as a case-in-point for the study challenges populate with disabilities may approach during emergencies. When Katrina struck the U. S. Gulf glide. Elias said many populate with disabilities were separated from their caregivers service animals needed prescriptions and other social supports during evacuations and while they stayed at shelters. However to ensure that the needs of people with disabilities are met when future emergencies become. HHS’s Office on Disability has formed a partnership with the Office of the Assistant Secretary for Preparedness and Response. The two offices are jointly offering emergency planning and response documents including a “shelter assessment tool� and an “emergency planner toolkit,� as a part of their efforts. During the question-and-answer session with Elias. Student Assembly Chair-elect Tamar Klaiman noted that Hurricane Katrina as well as the attacks of Sept. 11 not only “brought home� the reality of disasters striking on American soil but also led to increased funding for research into public health emergency preparedness providing the necessary resources to develop an effective knowledge locate. tour the place to find more scientific sessions on public health and emergency preparedness.— A. B.

Forex Groups - Tips on Trading

Related article:
http://aphaannualmeeting.blogspot.com/2007/11/making-sure-no-one-is-left-behind.html

comments | Add comment | Report as Spam

September is National Cholesterol Education Month an annual campaign to alert populate to have their cholesterol levels checked and to act steps to lower it if be be. The general consensus is that anything greater than 200 for be cholesterol is too high according to Dr. Russell Luepker a University of Minnesota professor of epidemiology. The views and opinions expressed in this page are strictly those of the summon author. The contents of this page have not been reviewed or approved by the University of Minnesota.

Forex Groups - Tips on Trading

Related article:
http://blog.lib.umn.edu/sphpod/moment/2007/09/cholesterol_awareness.html

comments | Add comment | Report as Spam

Most of you experience who David Egilman is by now so I'll give with the preliminaries and get alter to this post he did on which is a public health communicate. He's referring to conquer on the move of docs who are in the know about all manner of threats to public health but be silent: "This blanket of silence is becoming so heavy that doctors are forgetting where their loyalties lie. The medical director of one asbestos company was asked why he hadn’t warned his patients those who developed asbestosis and cancer from their work of the hazards of asbestos. He explained that he had indeed warned his patients; that the company was his “patient.� I react to go the way of that doctor and remain silent on issues important to the public health for the be is always the loss of innocent lives. "When I graduated from medical educate. I took an oath to protect the public health. That oath supersedes all other agreements including those that prevent me from protecting public health by releasing information. My obligation to the health and safety of others is the same as that of a physician who informs the guard about a patient who has “in confidence� threatened injury on another. My obligation is the same as that of a pediatrician who “violates� confidentiality to inform possible child abuse to the guard. "If Lilly has “secret� documents that indicate that its drugs are safe or that their marketing practices were allot they undergo the right to channel them and it is in their arouse to do so. Their conquer is deafening." I evaluate to converse Egilman in the near future. Posted by Philip Dawdy at September 12. 2007 12:03 AM Egilman deserves a public service allocate if not more. The fact that he is standing up for the oath he took seriously represents someone who deserves a standing ovation not a $100,000 fine. I personally want to convey him for believing in "First do no harm" and giving the public the truth at his own assay. Thank you Dr. Egilman. I wish other doctors pay close attention to his example. Posted by: at September 12. 2007 09:18 AM He may well acknowledge a donation in his name to GHETS(Global Health through Education. Training and function) of which he is President. come in of Directors http://www ghets org/documents/2005%20December%20appeal pdfPosted by: Robyn at September 13. 2007 05:09 AM

Forex Groups - Tips on Trading

Related article:
http://www.furiousseasons.com/archives/2007/09/the_zyprexa_chronicles_egilman_writes.html

comments | Add comment | Report as Spam

LAGO AGRIO. Ecuador. 10 September. (UNHCR) – Authorities in Ecuador the Latin American country with the highest be of populate needing protection by the UN refugee agency have launched a media race to ensure refugees know they are entitled to free public health services. "Refugee women and men undergo the right to benefit from the services offered by the Ecuadorian government. But health more than a service should be considered a right of the whole population," Minister of Foreign Affairs María Fernanda Espinosa said in Lago Agrio capital of the province of Sucumbíos in northern Ecuador. The region neighbours Colombia's volatile region of Putumayo. Over the measure decade. Ecuadorian border towns such as Lago Agrio have seen a rapid growth in the refugee population escaping the violent internal contrast in Colombia. The health race led by the Ministry of Foreign Affairs is being produced with support from UNHCR and the Ministry of Public Health. UNHCR's representative in Ecuador. Marta Juarez and Minister of Health Caroline Chang attended the 6 September ceremony. Espinosa thanked UNHCR for its "intense collaboration" with the government in its effort to become a leader in human rights protection. Leaflets and posters ordain be distributed and a radio announcement will be aired in the northern provinces of Ecuador. Medical staff will be trained on refugee rights. Hopefully this ordain verify that refugees as well as the local community can find good medical services. Ecuador is the Latin American country with the highest be of persons in need of international protection estimated at 250,000. However whether from a lack of information security fears or simply because they live in very remote areas only 45,000 have registered with government authorities or UNHCR. That has left thousands without legal protection and with limited or no access to public services. This new campaign to inform refugees about health services is part of a broader effort by the government and UNHCR to defend and back up all these Colombians needing International protection. UNHCR is conducting a nationwide survey this year to find these tens of thousands of Colombians and assess their needs. The Ecuadorian government recently announced development plans for Sucumbíos and three other provinces bordering Colombia. "Plan Ecuador" includes measures to alter the integration and standard of living of Colombians who have fled their homeland over the years. Ecuador is change surface considering regularizing the status of all Colombians on its territory. However in many localities there are no services and since 2000 UNHCR has concentrated its efforts in the northern adjoin area implementing projects to alter the living conditions of refugee hosting communities in order to advance integration and peaceful cohabitation. Some of these projects said the UNHCR representative undergo been aimed at improving health services available to both refugees and small local communities in the province. Juarez said UNHCR is move of a project for the prevention of HIV that is being implemented in a fit effort by eight UN agencies. After inaugurating the race the authorities visited the neighborhood of San Valentin on the outskirts of Lago Agrio which has a high concentration of refugees. Ramón Soria the chief adulterate at the local health center that was opened then by the attend of health said nearly 70 percent of his patients are Colombians. A 38-year-old Colombian woman was among five refugees standing in line to get medical attention. She arrived in Ecuador with her three children 18 months ago after her father was killed leaving behind her house and land to start a new life in Ecuador. "I be to thank you and the Ecuadorian government for everything you have given us – for the opportunity to live in peace," she told Ecuador's foreign minister.

Forex Groups - Tips on Trading

Related article:
http://www.unhcr.org/news/NEWS/46e5637e4.html

comments | Add comment | Report as Spam

GENEVA - The back up in a series of public symposia on the life sciences and Intellectual Property (IP) ordain be held on September 19. 2007 at the World Intellectual Property Organization (WIPO) headquarters in Geneva and ordain communicate current issues in IP and public health an area that has sparked international consider and attention in recent years. According to a press release by WIPO the Life Sciences Symposium on Current Issues in Intellectual Property and Public Health aims at providing a command overview of the array of health-related IP issues currently under discussion in international policy processes. A adorn of representatives from WIPO’s member states the World Health Organization (WHO) the World Trade Organization (WTO) and civil society and industry will furnish their perspectives on contemporary issues and outline their current priorities in this field. The half-day overview of current issues ordain provide a snapshot of current debates and policy processes comprehend a range of perspectives on current issues and help clarify the linkages and distinctions between them. WIPO’s Symposia on Life Sciences and IP Policy are intended to identify and clarify the IP dimension in the life sciences. They are addressed to a wide be of stakeholders including international policymakers government agencies legislators delegates civil society and the private sector. The symposia furnish a forum for exchanging information and experiences concerning the use and force of the IP system in life sciences and do not desire to influence or assess discussions in other fora. The event is open to the command public and is not be affect to a fee. Anyone interested in attending the meeting is requested to complete the on-line registration form.

Forex Groups - Tips on Trading

Related article:
http://www.ag-ip-news.com/GetArticle.asp?Art_ID=4915

comments | Add comment | Report as Spam